Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and ...

With a rumored $8m price tag, the Super Bowl ad stakes are high – but the potential brand rewards are massive. How can ...

Hims & Hers' “Sick of the System” spot not only generated the highest engagement of all pharma-related ads that aired during ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment. It could begin competing with generic versions in the U.S. market in 2028, ...

Picking up from where last year's Big Game ad debut left off, Pfizer wants to bring a note of resilience and motivation to ...

Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Stocks of IndusInd Bank Ltd., Oil and Natural Gas Corp., Pfizer Ltd., Inox Wind Ltd. and Poonawalla Fincorp Ltd. were in focus on Saturday, after the companies announced their third quarter results.